drugset / Trial / NCT02492958

SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults

NCT02492958 ↗

Phase 2 Completed 136 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of a single dose of Staphylococcus aureus 4 antigen vaccine in Japanese adults aged 20 to \<86 years.

Timeline

Start
2015-06
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Staphylococcus aureus 4-antigen vaccine Vaccine 0.5 ml Intramuscular